[HTML][HTML] Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: a systematic review and meta-analysis

BV Ineichen, C Tsagkas, M Absinta, DS Reich - NeuroImage: Clinical, 2022 - Elsevier
Background The lack of systematic evidence on leptomeningeal enhancement (LME) on
MRI in neurological diseases, including multiple sclerosis (MS), hampers its interpretation in …

Deciphering multiple sclerosis progression

V Meca-Lallana, L Berenguer-Ruiz… - Frontiers in …, 2021 - frontiersin.org
Multiple sclerosis (MS) is primarily an inflammatory and degenerative disease of the central
nervous system, triggered by unknown environmental factors in patients with predisposing …

7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions

J Zurawski, S Tauhid, R Chu, F Khalid… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: Meningeal inflammation may contribute to gray matter (GM) involvement in
multiple sclerosis (MS) and is proposed to manifest as magnetic resonance imaging (MRI) …

Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study

R Zivadinov, D Jakimovski, M Ramanathan… - Multiple sclerosis and …, 2022 - Elsevier
Background Ocrelizumab is an effective treatment for relapsing and primary-progressive
multiple sclerosis (MS). However, the effect of ocrelizumab on leptomeningeal (LM) …

Imaging mechanisms of disease progression in multiple sclerosis: beyond brain atrophy

F Bagnato, SA Gauthier, C Laule… - Journal of …, 2020 - Wiley Online Library
Clinicians involved with different aspects of the care of persons with multiple sclerosis (MS)
and scientists with expertise on clinical and imaging techniques convened in Dallas, TX …

Imaging of the meningeal lymphatic network in healthy adults: a 7T MRI study

LD Patel, P Raghavan, S Tang, S Choi… - Journal of …, 2023 - Elsevier
Background and purpose Meningeal lymphatic vessels (MLVs) along the dural venous
sinuses are suspected to be important in connecting the glymphatic and peripheral …

Use of a commercial 7-T MRI scanner for clinical brain imaging: indications, protocols, challenges, and solutions—a single-center experience

C Özütemiz, M White, W Elvendahl… - American Journal of …, 2023 - Am Roentgen Ray Soc
The first commercially available 7-T MRI scanner (Magnetom Terra) was approved by the
FDA in 2017 for clinical imaging of the brain and knee. After initial protocol development and …

No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis

M Ighani, S Jonas, I Izbudak, S Choi… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: Autopsy data suggest a causative link between meningeal inflammation and
cortical lesions (CLs) in multiple sclerosis (MS). Objective: To use leptomeningeal …

Highly sensitive 3-Tesla real inversion recovery MRI detects leptomeningeal contrast enhancement in chronic active multiple sclerosis

SV Okar, H Dieckhaus, ES Beck, MI Gaitán… - Investigative …, 2024 - journals.lww.com
Background Leptomeningeal contrast enhancement (LME) on T2-weighted Fluid-Attenuated
Inversion Recovery (T2-FLAIR) MRI is a reported marker of leptomeningeal inflammation …

Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis

FE Hildesheim, DP Ramasamy, N Bergsland… - Multiple sclerosis and …, 2021 - Elsevier
Background: Leptomeningeal contrast enhancement (LMCE) has previously shown
potential to be an indirect marker for leptomeningeal inflammation in multiple sclerosis (MS) …